Alu Elements in ANRIL Non-Coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions through Trans-Regulation of Gene Networks
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
The chromosome 9p21 (Chr9p21) locus of coronary artery disease has been identified in the first surge of genome-wide association and is the strongest genetic factor of atherosclerosis known today. Chr9p21 encodes the long non-coding RNA (ncRNA) antisense non-coding RNA in the INK4 locus (ANRIL). ANRIL expression is associated with the Chr9p21 genotype and correlated with atherosclerosis severity. Here, we report on the molecular mechanisms through which ANRIL regulates target-genes in trans, leading to increased cell proliferation, increased cell adhesion and decreased apoptosis, which are all essential mechanisms of atherogenesis. Importantly, trans-regulation was dependent on Alu motifs, which marked the promoters of ANRIL target genes and were mirrored in ANRIL RNA transcripts. ANRIL bound Polycomb group proteins that were highly enriched in the proximity of Alu motifs across the genome and were recruited to promoters of target genes upon ANRIL over-expression. The functional relevance of Alu motifs in ANRIL was confirmed by deletion and mutagenesis, reversing trans-regulation and atherogenic cell functions. ANRIL-regulated networks were confirmed in 2280 individuals with and without coronary artery disease and functionally validated in primary cells from patients carrying the Chr9p21 risk allele. Our study provides a molecular mechanism for pro-atherogenic effects of ANRIL at Chr9p21 and suggests a novel role for Alu elements in epigenetic gene regulation by long ncRNAs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Identification of Alu motifs in promoters of ANRIL trans-regulated genes and ANRIL RNA and their spatial relation to PcG protein binding. (A) DNA motif in promoters (5 kb) of trans-regulated genes representing an Alu-DEIN repeat [33]. (B) Number of Alu motifs in promoters of trans- and not regulated transcripts (n per 5 kb). (C) ChIP-seq enrichment of SUZ12 and CBX7 binding distal to Alu motif, demonstrating a specific spatial relation of motif occurrence to PcG protein binding. RPM- reads per million mapped reads, CTR- random DNA control sequence. (D) Motif-associated SUZ12 signal peaks in an independent data set from BGO3 cells. The actual signal peak only becomes apparent, if a multiple matching policy is adopted. (E) Using a strict unique-matches only policy, a substantial signal reduction is seen downstream of the motif. Please note differences in y-axis scaling in (D, E). (F) Secondary RNA structure prediction for ANRIL2 using the Vienna RNA package [58]. Within the minimum free energy structure, the Alu-DEIN motif is located in a stem-loop structure (arrow). (G) RIP demonstrating ANRIL binding to histone H3 (H3) and trimethylated lysine 27 of histone 3 (H3K27me3) in ANRIL2 (blue) and ANRIL4 (red) cells. U1 was used as negative control. mIgG/rIgG- mouse/rabbit IgG control. Error bars indicate s.e.m.](https://figures.cochat.ai/paper-figures/3d38d7a9963e478499e2c0998ca5fa70/alu-elements-in-anril-non-coding-rna-at-chromosome-9p21-modulate-atherogenic-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Chr9p21 encodes the long non-coding RNA(ncRNA) ANRIL, which has been demonstrated to regulate cell proliferation, adhesion and apoptosis,(43, 44) - central mechanisms of atherogenesis (13, 43) and endometriosis. (2, 3)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220 · cited 2×
“Associations of haplotypes with expression profiles, and correlation with ANRIL (Ex1-5, Ex18-19) were calculated using robust linear regression models as described (please refer to Supplemental Materials in [6]) with the R software for statistical computing [54].”
MethodMEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648 · cited 2×
“The MEME package [57] was used to search for differences in motifs abundance in promoters (5 kb) of differentially regulated genes.”
MethodAdjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658 · cited 1×
“Preprocessing of genome-wide expression data in PBMC of the Leipzig LIFE Heart Study comprised selection of expressed features, outlier detection, normalization, and batch correction as described [52,53].”
MethodLong non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654 · cited 1×
“Here, it was predicted to form a stem-loop structure in ANRIL RNA (Figure 4F) suggesting RNA-chromatin interactions as a potential effector mechanism [16].”
BackgroundLong non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218 · cited 2×
“On the mechanistic level, it has been postulated that long ncRNA may serve as a scaffold, guiding effector-proteins to chromatin [24–26,37–39].”
BackgroundLusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244 · cited 1×
“Among the best studied examples is the long ncRNA HOTAIR, which is transcribed from the HOXC cluster and was shown to repress genes in the HOXD cluster in trans [25,26].”
BackgroundThe Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347 · cited 1×
“PRCs are multiprotein complexes, responsible for initiating and maintaining epigenetic chromatin modifications and thereby controlling gene expression [21].”
BackgroundLong Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“Among the best studied examples is the long ncRNA HOTAIR, which is transcribed from the HOXC cluster and was shown to repress genes in the HOXD cluster in trans [25,26].”
Background
Cited by
Gene regulation by long non-coding RNAs and its biological functions
Statello, L., Guo, C.-J., Chen, L.-L., & Huarte, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00315-9 · Cited by 4,991
The Landscape of long noncoding RNA classification
St. Laurent, G., Wahlestedt, C., & Kapranov, P. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.03.007 · Cited by 1,191
“Considering the growing role of trans regulation by ncRNAs via intermolecular interactions [42, 82, 119], the fact that a lncRNA associates with an enhancer, promoter, or intron, or is antisense to a known gene may not reflect the actual function of that ncRNA.”
Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans
Holdt, L. M., Stahringer, A., Sass, K., Pichler, G., Kulak, N. A., Wilfert, W., Kohlmaier, A., Herbst, A., Northoff, B. H., Nicolaou, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12429 · Cited by 1,094
Self-citationLong Noncoding RNAs in Cardiovascular Diseases
Uchida, S., & Dimmeler, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.302521 · Cited by 739
“Inhibitions of several ANRIL isoforms containing exon 13 also reduced cell proliferation,(63) whereas its overexpression promoted cell growth, metabolic activity, and cell adhesion of tumor cell lines.(65) In addition, some studies suggested a role of the 9p21 locus in the inflammatory response of endothelial cells.”
Evolution to the rescue: using comparative genomics to understand long non-coding RNAs
Ulitsky, I. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.85 · Cited by 542
Boon, R. A., Jaé, N., Holdt, L., & Dimmeler, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.051 · Cited by 516
Self-citationEnhancer RNAs and regulated transcriptional programs
Lam, M. T. Y., Li, W., Rosenfeld, M. G., & Glass, C. K. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.007 · Cited by 505
Small and long non-coding RNAs: Past, present, and future
Chen, L.-L., & Kim, V. N. (2024) · Cell · doi:10.1016/j.cell.2024.10.024 · Cited by 425
Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links
De Rosa, S., Arcidiacono, B., Chiefari, E., Brunetti, A., Indolfi, C., & Foti, D. P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00002 · Cited by 369
“Recently, it has been hypothesized that the regulation of CDKN2B gene expression by lncANRIL could be involved in glucose homeostasis (71), while in diabetic patients, high glucose could alter ANRIL expression, favoring cell adhesion and cell proliferation, thereby leading to atherosclerosis (72).”
BackgroundMolecular roles and function of circular RNAs in eukaryotic cells
Holdt, L. M., Kohlmaier, A., & Teupser, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2688-5 · Cited by 343
Self-citationBasic biology and therapeutic implications of lncRNA
Khorkova, O., Hsiao, J., & Wahlestedt, C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.012 · Cited by 341
“ANRIL may be involved in development of atherosclerosis because the Chr9p21 atherosclerosis risk allele is associated with increased ANRIL expression [14].”
BackgroundThe RIDL hypothesis: transposable elements as functional domains of long noncoding RNAs
Johnson, R., & Guigó, R. (2014) · RNA · doi:10.1261/rna.044560.114 · Cited by 309
“For example, the SINEB2 domain of the Uchl1-as transcript regulates localization to the ribosome (Carrieri et al. 2012), or the Alu domain of ANRIL with chromatin (Holdt et al. 2013).”
BackgroundInfluentialCircular RNAs: a new frontier in the study of human diseases
Chen, Y., Li, C., Tan, C., & Liu, X. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103758 · Cited by 293
Stellos, K., Gatsiou, A., Stamatelopoulos, K., Perisic Matic, L., John, D., Lunella, F. F., Jaé, N., Rossbach, O., Amrhein, C., Sigala, F., et al. (2016) · Nature Medicine · doi:10.1038/nm.4172 · Cited by 285
Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy
Bär, C., Chatterjee, S., & Thum, T. (2016) · Circulation · doi:10.1161/circulationaha.116.023686 · Cited by 267
Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
Bure, I. V., Nemtsova, M. V., & Kuznetsova, E. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105801 · Cited by 253
A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection
Hoffmann, S., Otto, C., Doose, G., Tanzer, A., Langenberger, D., Christ, S., Kunz, M., Holdt, L. M., Teupser, D., Hackermüller, J., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r34 · Cited by 270
Self-citationLong non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway
Zhou, X., Han, X., Wittfeldt, A., Sun, J., Liu, C., Wang, X., Gan, L.-M., Cao, H., & Liang, Z. (2016) · RNA Biology · doi:10.1080/15476286.2015.1122164 · Cited by 240
“Existing evidence already suggested that YY1 might bind ANRIL in cells.(24) In this work we demon-”
BackgroundEndometriosis and Risk of Coronary Heart Disease
Mu, F., Rich-Edwards, J., Rimm, E. B., Spiegelman, D., & Missmer, S. A. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002224 · Cited by 235
“(40-42) Chr9p21 encodes the long non-coding RNA(ncRNA) ANRIL, which has been demonstrated to regulate cell proliferation, adhesion and apoptosis,(43, 44) - central mechanisms of atherogenesis (13, 43) and endometriosis.”
Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
von Scheidt, M., Zhao, Y., Kurt, Z., Pan, C., Zeng, L., Yang, X., Schunkert, H., & Lusis, A. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.001 · Cited by 221
“For example, the most impactful human GWAS locus, on chromosome 9p21, is probably mediated by changes in the expression of a long noncoding RNA, ANRIL, that is not conserved in themouse (Holdt et al., 2013).”
BackgroundLong noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression
Shih, J.-W., Chiang, W.-F., Wu, A. T. H., Wu, M.-H., Wang, L.-Y., Yu, Y.-L., Hung, Y.-W., Wang, W.-C., Chu, C.-Y., Hung, C.-L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15874 · Cited by 213
“It has been reported that repetitive sequence elements in lncRNAs contribute to RNA-chromatin interactions 56 .”
ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
Kong, Y., Hsieh, C.-H., & Alonso, L. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00405 · Cited by 207
Long noncoding RNA dysregulation in ischemic heart failure
Greco, S., Zaccagnini, G., Perfetti, A., Fuschi, P., Valaperta, R., Voellenkle, C., Castelvecchio, S., Gaetano, C., Finato, N., Beltrami, A. P., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0926-5 · Cited by 202
“Nonetheless, CDKN2B-AS1 RNA expression has been shown to stimulate cell proliferation, adhesion, and to reduce apoptosis, providing a potential atherosclerosis disease mechanism [63].”
BackgroundNon-coding RNAs in cardiovascular cell biology and atherosclerosis
Fasolo, F., Di Gregoli, K., Maegdefessel, L., & Johnson, J. L. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz203 · Cited by 201
High susceptibility to fatty liver disease in two-pore channel 2-deficient mice
Grimm, C., Holdt, L. M., Chen, C.-C., Hassan, S., Müller, C., Jörs, S., Cuny, H., Kissing, S., Schröder, B., Butz, E., et al. (2014) · Nature Communications · doi:10.1038/ncomms5699 · Cited by 200
Self-citationDNA Methylation of Lipid-Related Genes Affects Blood Lipid Levels
Pfeiffer, L., Wahl, S., Pilling, L. C., Reischl, E., Sandling, J. K., Kunze, S., Holdt, L. M., Kretschmer, A., Schramm, K., Adamski, J., et al. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000804 · Cited by 194
“One challenge of genome-wide DNA methylation analyses in blood samples is the difference in methylation patterns between different blood cell types.(10,14) In our blood cell expression panel of ABCG1, CPT1A, and SREBF1, varying expression patterns were also detectable (Figure I in the Data Supplement), which underline…”
Self-citationEpigenetics of Atherosclerosis: Emerging Mechanisms and Methods
Khyzha, N., Alizada, A., Wilson, M. D., & Fish, J. E. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.004 · Cited by 193
Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease
Yang, Y., Cai, Y., Wu, G., Chen, X., Liu, Y., Wang, X., Yu, J., Li, C., Chen, X., Jose, P. A., et al. (2015) · Clinical Science · doi:10.1042/cs20150121 · Cited by 186
Long non‐coding RNA regulation of reproduction and development
Taylor, D. H., Chu, E. T., Spektor, R., & Soloway, P. D. (2015) · Molecular Reproduction and Development · doi:10.1002/mrd.22581 · Cited by 187
“…(cyclindependent kinase inhibitor 2BantisenseRNA1) both contain and require Alu elements for their ANRIL/CDKN2B-AS1 response yet not all Alu elements respond to ANRIL/ CDKN2B-AS1, so it is not clear what provides specificity forAluelementsatANRIL/CDKN2B-AS1 target genes (Holdt et al., 2013).”
BackgroundDurruthy-Durruthy, J., Sebastiano, V., Wossidlo, M., Cepeda, D., Cui, J., Grow, E. J., Davila, J., Mall, M., Wong, W. H., Wysocka, J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3449 · Cited by 181
The lncRNA MIR31HG regulates p16INK4A expression to modulate senescence
Montes, M., Nielsen, M. M., Maglieri, G., Jacobsen, A., Højfeldt, J., Agrawal-Singh, S., Hansen, K., Helin, K., van de Werken, H. J. G., Pedersen, J. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7967 · Cited by 173
Kessler, T., Vilne, B., & Schunkert, H. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506174 · Cited by 173
“…different isoforms of ANRIL and subsequently to preferred synthesis of non-circular/circular forms of this long non-coding RNA, which affect via ribosomal function the expression of multiple genes leading ultimately to opposing effects on cell proliferation and apoptosis (Holdt et al, 2010, 2013).”
BackgroundA pathophysiological view of the long non-coding RNA world
Di Gesualdo, F., Capaccioli, S., & Lulli, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2770 · Cited by 165
Epigenetic regulation: A new frontier for biomedical engineers
Chen, Z., Li, S., Subramaniam, S., Shyy, J. Y.-J., & Chien, S. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044720 · Cited by 163
RNA Therapeutics in Cardiovascular Disease
Lucas, T., Bonauer, A., & Dimmeler, S. (2018) · Circulation Research · doi:10.1161/circresaha.117.311311 · Cited by 156
Mahmoud, A. D., Ballantyne, M. D., Miscianinov, V., Pinel, K., Hung, J., Scanlon, J. P., Iyinikkel, J., Kaczynski, J., Tavares, A., Bradshaw, A. C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314876 · Cited by 161
“46 Here, we showed that SMILR specifically targets the late mitotic pathway in proliferating HSVSMCs and interacts with CENPF mRNA and STAU1.”
Li, L., Wang, L., Li, H., Han, X., Chen, S., Yang, B., Hu, Z., Zhu, H., Cai, C., Chen, J., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.866 · Cited by 162
Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases
Gupta, S. C., Awasthee, N., Rai, V., Chava, S. P., Gunda, V., & Challagundla, K. B. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188316 · Cited by 149
Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer
Bernhart, S. H., Kretzmer, H., Holdt, L. M., Jühling, F., Ammerpohl, O., Bergmann, A. K., Northoff, B. H., Doose, G., Siebert, R., Stadler, P. F., et al. (2016) · Scientific Reports · doi:10.1038/srep37393 · Cited by 125
Self-citationWarren, I. A., Naville, M., Chalopin, D., Levin, P., Berger, C. S., Galiana-Arnoux, D., & Volff, J. (2015) · Chromosome Research · doi:10.1007/s10577-015-9493-5 · Cited by 141
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing
Lo Sardo, V., Chubukov, P., Ferguson, W., Kumar, A., Teng, E. L., Duran, M., Zhang, L., Cost, G., Engler, A. J., Urnov, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.014 · Cited by 124
“Indeed, the number of differentially regulated genes we have uncovered ( 3,000) (Table S6) is significantly greater than those reported using gene chip-based profiling of human cell lines ( 200–700) (Holdt et al., 2013).”
Cai, Y., Yang, Y., Chen, X., Wu, G., Zhang, X., Liu, Y., Yu, J., Wang, X., Fu, J., Li, C., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw022 · Cited by 117
Noncoding RNA in age-related cardiovascular diseases
Greco, S., Gorospe, M., & Martelli, F. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.011 · Cited by 120
“Functional studies showed thatANRIL expression stimulates cell proliferation, promotes adhesion, and decreases apoptosis, providing a potential disease mechanism, at least for atherosclerosis [144].”
BackgroundGuo, F., Tang, C., Li, Y., Liu, Y., Lv, P., Wang, W. T., & Mu, Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13790 · Cited by 124
Long Noncoding RNAs in Atherosclerosis
Zhang, Z., Salisbury, D. A., & Sallam, T. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2161 · Cited by 120
Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis
Kumar, S., Williams, D., Sur, S., Wang, J., & Jo, H. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.001 · Cited by 120
Bai, Y., Nie, S., Jiang, G., Zhou, Y., Zhou, M., Zhao, Y., Li, S., Wang, F., Lv, Q., Huang, Y., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.003393 · Cited by 119
“Importantly, transregulation was dependent on Alu motifs that marked the promoters of ANRIL target genes and were mirrored in ANRIL RNA transcripts.(20) As with other downstream target genes, the detailed mechanism by which ANRIL regulates CARD8 expression remains to be identified.”
Into the Wild: GWAS Exploration of Non-coding RNAs
Giral, H., Landmesser, U., & Kratzer, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00181 · Cited by 125
Mechanisms of Long Noncoding RNA Nuclear Retention
Guo, C., Xu, G., & Chen, L. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.07.001 · Cited by 121
Multi-omics approaches for revealing the complexity of cardiovascular disease
Doran, S., Arif, M., Lam, S., Bayraktar, A., Turkez, H., Uhlen, M., Boren, J., & Mardinoglu, A. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab061 · Cited by 109
Gomes, C. P. C., Spencer, H., Ford, K. L., Michel, L. Y. M., Baker, A. H., Emanueli, C., Balligand, J.-L., & Devaux, Y. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.07.014 · Cited by 109
LncRNAs: emerging players in gene regulation and disease pathogenesis
Kazemzadeh, M., Safaralizadeh, R., & Orang, A. (2015) · Journal of Genetics · doi:10.1007/s12041-015-0561-6 · Cited by 111
Holdt, L. M., & Teupser, D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00145 · Cited by 112
Self-citationComparison of splice sites reveals that long noncoding RNAs are evolutionarily well conserved
Nitsche, A., Rose, D., Fasold, M., Reiche, K., & Stadler, P. F. (2015) · RNA · doi:10.1261/rna.046342.114 · Cited by 124
“…view is supported by major differences between isoforms, e.g., in the association of their expression levels with disease phenotypes (Burd et al. 2010; Holdt et al. 2010, 2013) or the change of function of HOTAIR in mouse that correlates with the loss of several exons (Schorderet and Duboule 2011).”
Self-citationDoose, G., Haake, A., Bernhart, S. H., López, C., Duggimpudi, S., Wojciech, F., Bergmann, A. K., Borkhardt, A., Burkhardt, B., Claviez, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505753112 · Cited by 106
“The functional relevance of this large amount of noncoding transcripts remains mostly unknown, but the number of reports showing effects on cellular physiology and aberrant expression in several diseases is quickly increasing (21 – 25).”
Self-citationLong Noncoding RNA: Recent Updates in Atherosclerosis
Li, H., Zhu, H., & Ge, J. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14430 · Cited by 102
“SMC ANRIL[28-35] Antisense Nucleus Guide, scaffold CDKN2A/B Proliferation ↑/ adhesion ↑/ apoptosis ↓”
BackgroundLong Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease
Aguiló, F., Cecilia, S. D., & Walsh, M. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_455 · Cited by 109
Noncoding RNAs and Atherosclerosis
Aryal, B., Rotllan, N., & Fernández-Hernando, C. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0407-3 · Cited by 94
Naemura, M., Murasaki, C., Inoue, Y., Okamoto, H., & Kotake, Y. (2015) · Anticancer Research · Cited by 99
Dynamic Alu Methylation during Normal Development, Aging, and Tumorigenesis
Luo, Y., Lu, X., & Xie, H. (2014) · BioMed Research International · doi:10.1155/2014/784706 · Cited by 91
Islet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 104
Kirsten, H., Al-Hasani, H., Holdt, L., Gross, A., Beutner, F., Krohn, K., Horn, K., Ahnert, P., Burkhardt, R., Reiche, K., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv194 · Cited by 94
“sion BeadChips (Illumina, San Diego, CA, USA) in batches of 48 and scanned on the Illumina iScan instrument according to the manufacturer’s specifications (67).”
BackgroundMethodSelf-citationReverse-genetics studies of lncRNAs—what we have learnt and paths forward
Gao, F., Cai, Y., Kapranov, P., & Xu, D. (2020) · Genome biology · doi:10.1186/s13059-020-01994-5 · Cited by 109
Characterizing the “POAGome”: A bioinformatics-driven approach to primary open-angle glaucoma
Danford, I. D., Verkuil, L. D., Choi, D. J., Collins, D. W., Gudiseva, H. V., Uyhazi, K. E., Lau, M. K., Kanu, L. N., Grant, G. R., Chavali, V. R. M., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.02.001 · Cited by 90
Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease
Leeper, N. J., & Mäegdefessel, L. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx249 · Cited by 90
Epigenetic reprogramming of immune cells in injury, repair, and resolution
Placek, K., Schultze, J. L., & Aschenbrenner, A. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124619 · Cited by 91
Häntzsch, M., Tolios, A., Beutner, F., Nagel, D., Thiery, J., Teupser, D., & Holdt, L. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113298 · Cited by 83
Self-citationLncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a/Sirt1
Tan, P., Guo, Y., Zhan, J., Long, L., Xu, M., Ye, L., Ma, X., Cui, X., & Wang, H. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0126 · Cited by 84
Ancient exapted transposable elements promote nuclear enrichment of human long noncoding RNAs
Carlevaro-Fita, J., Polidori, T., Das, M., Navarro, C., Zoller, T. I., & Johnson, R. (2019) · Genome Research · doi:10.1101/gr.229922.117 · Cited by 77
Emerging roles and mechanisms of long noncoding RNAs in atherosclerosis
Liu, Y., Zheng, L., Wang, Q., & Hu, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.182 · Cited by 80
From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
Gutschner, T., Richtig, G., Haemmerle, M., & Pichler, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9718-5 · Cited by 83
“promoters of ANRIL target genes and which are mirrored in ANRIL [113].”
BackgroundZhang, D., Wang, W.-T., Xiong, J., Xie, X.-M., Cui, S.-S., Zhao, Z.-G., Li, M. J., Zhang, Z., Hao, D., Zhao, X., et al. (2017) · Scientific Reports · doi:10.1038/srep46204 · Cited by 81
Epigenetic associations in relation to cardiovascular prevention and therapeutics
Voelter‐Mahlknecht, S. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0170-0 · Cited by 79
Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease
Gäbel, G., Northoff, B. H., Weinzierl, I., Ludwig, S., Hinterseher, I., Wilfert, W., Teupser, D., Doderer, S. A., Bergert, H., Schönleben, F., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006798 · Cited by 79
“Microarray Analysis Transcriptome-wide expression analysis was performed using the Illumina (San Diego, CA) HumanHT-12 v4 Expression BeadChip platform as previously described.(8) Background correction and quantile normalization were performed by the limma package(9) used in R version 3.”
MethodSelf-citationLong non‐coding RNAs in corticogenesis: deciphering the non‐coding code of the brain
Aprea, J., & Calegari, F. (2015) · The EMBO Journal · doi:10.15252/embj.201592655 · Cited by 74
Liu, Y., Ferguson, J. F., Xue, C., Ballantyne, R. L., Silverman, I. M., Gosai, S. J., Serfecz, J. C., Morley, M. P., Gregory, B. D., Li, M., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303123 · Cited by 72
Genome-Wide Association Studies of Hypertension and Several Other Cardiovascular Diseases
Wang, Y., & Wang, J. (2018) · Pulse · doi:10.1159/000496150 · Cited by 74
Long Noncoding RNAs and Cardiac Disease
Greco, S., Salgado‐Somoza, A., Devaux, Y., & Martelli, F. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7126 · Cited by 72
“The mechanism of transcriptional modulation mediated by ANRIL relies on the interaction with PRC2 and results in cell proliferation stimulation, promotion of cell adhesion, and reduction of apoptosis, providing a potential causative mechanism for atherosclerosis (67) (Fig.”
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
Cheng, H. S., Njock, M.-S., Khyzha, N., Dang, L. T., & Fish, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00422 · Cited by 69
“ABs, the largest vesicles (1–5 μm), are membrane blebs released from apoptotic cells (Hristov et al., 2004).”
BackgroundCho, H., Shen, G.-Q., Wang, X., Wang, F., Archacki, S. R., Li, Y., Yu, G., Chakrabarti, S., Chen, Q., & Wang, Q. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005050 · Cited by 72
“Several studies suggested cis- and trans-gene regulatory functions of ANRIL through epigenetic mechanisms (9, 10, 14).”
BackgroundmiR-103 promotes endothelial maladaptation by targeting lncWDR59
Natarelli, L., Geißler, C., Csaba, G., Wei, Y., Zhu, M., di Francesco, A., Hartmann, P., Zimmer, R., & Schober, A. (2018) · Nature Communications · doi:10.1038/s41467-018-05065-z · Cited by 72
Recent advances on the roles of LncRNAs in cardiovascular disease
Fang, Y., Xu, Y., Wang, R., Hu, L., Guo, D. S., Xue, F., Guo, W., Zhang, D., Hu, J., Li, Y., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15880 · Cited by 67
Mongelli, A., Martelli, F., Farsetti, A., & Gaetano, C. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00369 · Cited by 70
“Recently, circANRIL has been found involved in atherosclerosis because of its function as ribosomal RNA maturation modulator (Holdt et al., 2016).”
BackgroundInfluentialMessemaker, T. C., Frank‐Bertoncelj, M., Marques, R. B., Adriaans, A. E., Bakker, A. M., Daha, N. A., Gay, S., Huizinga, T. W. J., Toes, R. E. M., Mikkers, H. M. M., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.54 · Cited by 69
Epigenetic Reprogramming in Atherosclerosis
Grimaldi, V., Vietri, M. T., Schiano, C., Picascia, A., Pascale, M. R. D., Fiorito, C., Casamassimi, A., & Claudio Napoli, A. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0476-3 · Cited by 69
Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis
Chi, J., Li, J.-Z., Jia, J., Zhang, T., Liu, X.-M., & Yi, L. (2017) · Current Medical Science · doi:10.1007/s11596-017-1812-y · Cited by 78
The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis
Nguyen, T. M., Kabotyanski, E. B., Reineke, L. C., Shao, J., Xiong, F., Lee, J.-H., Dubrulle, J., Johnson, H. L., Stossi, F., Tsoi, P. S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1176 · Cited by 70
“Activated caspase-3 cleaves TDP-43 FL into its truncated form TDP-43 CTF35 (3), that predominantly localizes to the cytoplasm (4) and forms more cytotoxic TDP-43 inclusions (5).”
BackgroundFrom genotype to phenotype in human atherosclerosis - recent findings
Holdt, L. M., & Teupser, D. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283654e7c · Cited by 62
Self-citationNitsche, A., & Stadler, P. F. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1376 · Cited by 83
Self-citationMorales‐Hernández, A., González-Rico, F. J., Román, Á., Rico-Leo, E. M., Alvarez, A. M., Sánchez, L., Macia, Á., Heras, S. R., Garcia-Perez, J. L., Merino, J. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw095 · Cited by 66
“Such mechanism would resemble the one recently proposed for the long non-coding RNA ANRIL that regulates atherosclerosis genes in trans by means of an Alu element present in its sequence (7).”
BackgroundInfluentialLü, W., Huang, S. Y., Su, L., Zhao, B. X., & Miao, J. Y. (2016) · Scientific Reports · doi:10.1038/srep21620 · Cited by 64
Skuratovskaia, D., Vulf, M. A., Komar, A., Кириенкова, Е. В., & Litvinova, L. S. (2019) · Biomolecules · doi:10.3390/biom9060226 · Cited by 60
“In addition to acting in the cis-conformation, ANRIL acts in the trans-conformation (through Alu elements) to regulate other genes that are involved in proatherogenic pathways (Figure 3) [119].”
BackgroundSun, G., Li, Y., & Ji, Z. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1628116 · Cited by 58
“In recent years, the circulating levels of several lncRNAs, such as LincP21 and ANRIL, are markedly elevated in AS, which may be essential in the pathogenesis of AS (Harismendy et al., 2011; Holdt et al., 2013; Bai et al., 2014).”
BackgroundOliveira-Mateos, C., Sánchez‐Castillo, A., Soler, M., Obiols-Guardia, A., Piñeyro, D., Boqué-Sastre, R., Calleja-Cervantes, M. E., de Moura, M. C., Martínez‐Cardús, A., Rubio, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11910-6 · Cited by 62
Long non-coding RNAs in vascular biology and disease
Jaé, N., Heumüller, A. W., Fouani, Y., & Dimmeler, S. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.03.003 · Cited by 62
Chen, L., Qu, H., Guo, M. H., Zhang, Y., Cui, Y., Yang, Q., Bai, R., & Shi, D. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13060 · Cited by 64
Transposable Element Insertions in Long Intergenic Non-Coding RNA Genes
Kannan, S., Chernikova, D. A., Rogozin, I. B., Poliakov, E., Managadze, D., Koonin, E. V., & Milanesi, L. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00071 · Cited by 76
Epigenetics in the Vascular Endothelium: Looking From a Different Perspective in the Epigenomics Era
Yan, M. S., & Marsden, P. A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305043 · Cited by 69
“adhesion, which might support its proatherogenic function.(73) Importantly, ANRIL regulates the expression of genes associated with these processes.”
The emerging roles of long noncoding RNAs in common cardiovascular diseases
Jiang, X., & Ning, Q. (2015) · Hypertension Research · doi:10.1038/hr.2015.26 · Cited by 55
Molecular functions and specific roles of circRNAs in the cardiovascular system
Holdt, L. M., Kohlmaier, A., & Teupser, D. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.05.002 · Cited by 56
“On the other hand, ANRIL can also interact with transcriptional coactivators to alter the transcription of target genes in trans and, thereby, affect cell adhesion, apoptosis and inflammation in ways that stimulate atherosclerosis [164,165].”
BackgroundSelf-citation
Metadata
- Authors
- Holdt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K., Finstermeier, K., Stahringer, A., Wilfert, W., Beutner, F., Gielen, S., Schuler, G., Gäbel, G., Bergert, H., Bechmann, I., Stadler, P. F., Thiery, J., & Teupser, D.
- Affiliations
- University Hospital Leipzig (DE)
- Leipzig University (DE)
- Technische Universität Dresden (DE)
- Santa Fe Institute (US)
- Corresponding author
- Teupser, Daniel
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-04
- Volume
- 9
- Issue
- 7
- Pages
- e1003588
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3701717
- OpenAlex
- W1972104572
- Cited by
- 397
- References
- 62
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 12 · 2023: 18 · 2022: 36 · 2021: 33 · 2020: 42 · 2019: 38 · 2018: 40 · 2017: 43 · 2016: 37 · 2015: 41 · 2014: 27 · 2013: 3
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- European Commission
- Freistaat Sachsen
- European Regional Development Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- ANRIL, Alu elements, chromosome 9p21, long non-coding RNA, trans-regulation, atherosclerosis, coronary artery disease, Polycomb group proteins, epigenetic regulation, cell proliferation, cell adhesion, apoptosis, risk alleles
- MeSH terms
- Cell Adhesion, Chromosomes, Human, Pair 9, Coronary Artery Disease, Gene Expression Regulation, Humans, Apoptosis, Genetic Predisposition to Disease, Alu Elements, Polymorphism, Single Nucleotide, Epigenesis, Genetic, Cell Proliferation, Atherosclerosis, Gene Regulatory Networks, Genome-Wide Association Study, HEK293 Cells, RNA, Long Noncoding, Polycomb-Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.